Asset Allocation

As of January 31, 2026.
Type % Net
Cash 0.15%
Stock 60.04%
Bond 37.72%
Convertible 0.00%
Preferred 1.30%
Other 0.79%
View Asset Allocation
Start Trial

Market Capitalization

As of January 31, 2026
Large 67.50%
Mid 21.44%
Small 11.05%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 96.30%    % Emerging Markets: 0.00%    % Unidentified Markets: 3.70%

Americas 80.99%
80.03%
Canada 1.51%
United States 78.52%
0.96%
As of January 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 13.96%
United Kingdom 3.16%
10.80%
France 0.03%
Germany 0.60%
Ireland 6.09%
Italy 0.16%
Netherlands 0.82%
Switzerland 3.11%
0.00%
0.00%
Greater Asia 1.36%
Japan 0.65%
0.04%
Australia 0.04%
0.67%
Hong Kong 0.30%
South Korea 0.38%
0.00%
Unidentified Region 3.70%

Bond Credit Quality Exposure

AAA 11.66%
AA 35.28%
A 12.88%
BBB 18.76%
BB 0.09%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 3.21%
Not Available 18.12%
Short Term 0.00%
As of January 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
34.07%
Materials
3.67%
Consumer Discretionary
5.17%
Financials
25.23%
Real Estate
0.00%
Sensitive
31.22%
Communication Services
5.48%
Energy
6.27%
Industrials
11.81%
Information Technology
7.66%
Defensive
33.39%
Consumer Staples
8.96%
Health Care
19.35%
Utilities
5.08%
Not Classified
1.33%
Non Classified Equity
1.33%
Not Classified - Non Equity
0.00%
As of January 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of January 31, 2026
Type % Net
Government 25.39%
Corporate 32.19%
Securitized 41.17%
Municipal 0.95%
Other 0.31%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.91%
Less than 1 Year
0.91%
Intermediate
48.36%
1 to 3 Years
12.55%
3 to 5 Years
11.85%
5 to 10 Years
23.96%
Long Term
49.81%
10 to 20 Years
16.81%
20 to 30 Years
28.95%
Over 30 Years
4.05%
Other
0.92%
As of January 31, 2026
View Bond Maturity Exposure
Start Trial